Home / Countries / Netherlands / HIV medicines

Netherlands · availability and reimbursement

HIV medicines in The Netherlands

Of 37 verified HIV medicine records for the Netherlands, 33 are available and reimbursed (89%), 2 are available but not reimbursed and 2 are not available. 5 further records are still under review.

89% of verified records reimbursed

Last checked 02/11/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 33

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Emtriva, Epivir, Eviplera, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Kivexa, Norvir, Odefsey, Pifeltro, Prezista, Rekambys, Retrovir, Reyataz, Rezolsta, Stribild, Symtuza, Tivicay, Triumeq, Truvada, Viread, Vocabria, Vocabria / Rekambys, Ziagen

Available, not reimbursed 2

Rukobia, Sunlenca

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 5

Apretude, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Evotaz, Yeytuo

See every medicine with its source →

More about the Netherlands

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Netherlands profile

Neighbouring countries

GermanyBelgiumLuxembourgDenmark

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.